Avantax Advisory Services Inc. Acquires 18,012 Shares of HCA Healthcare, Inc. $HCA

Avantax Advisory Services Inc. raised its position in HCA Healthcare, Inc. (NYSE:HCA) by 223.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 26,089 shares of the company’s stock after purchasing an additional 18,012 shares during the period. Avantax Advisory Services Inc.’s holdings in HCA Healthcare were worth $9,995,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Cheviot Value Management LLC acquired a new position in HCA Healthcare in the first quarter valued at about $26,000. Saudi Central Bank bought a new position in shares of HCA Healthcare in the 1st quarter valued at about $26,000. WPG Advisers LLC bought a new position in shares of HCA Healthcare in the first quarter valued at $27,000. Ameriflex Group Inc. bought a new stake in HCA Healthcare during the second quarter worth $27,000. Finally, Chung Wu Investment Group LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth about $27,000. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $477.07 on Tuesday. The company has a market cap of $108.86 billion, a price-to-earnings ratio of 18.44, a PEG ratio of 1.38 and a beta of 1.41. The stock has a fifty day moving average price of $434.74 and a 200-day moving average price of $397.75. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $480.00.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period last year, the firm earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Analyst Ratings Changes

A number of equities analysts recently commented on HCA shares. Bank of America lifted their price target on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a report on Monday, October 27th. JPMorgan Chase & Co. boosted their target price on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. TD Cowen lifted their price objective on shares of HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. Finally, Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $474.53.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.